Treatment of polycythemia vera with recombinant interferon

A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Leukemia·2026

Automated Information Extraction from Unstructured Hematopathology Reports to Support Response Assessment in Myeloproliferative Neoplasms.

Methods of information in medicine·2025

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Blood·2025

Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).

Transplantation and cellular therapy·2024

A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.

Annals of hematology·2024

Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.

Blood advances·2024

Timing of autologous stem cell transplantation and induction response in central nervous system lymphoma.

International journal of hematology·2026

Voriconazole versus itraconazole for antifungal prophylaxis in patients with graft-versus-host disease: A prospective randomized trial.

International journal of hematology·2026

Diagnostic delay and clinical outcomes of paroxysmal nocturnal hemoglobinuria: a retrospective cohort study using Japanese claims data.

International journal of hematology·2026

Dimensionality reduction enables MRD visualization in single-sample flow cytometric analysis in acute leukemia.

International journal of hematology·2026

Metabolic mimic of inherited bone marrow failure: LMBRD1 (cblF) deficiency in an infant.

International journal of hematology·2026

Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold.

International journal of hematology·2026

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

European journal of haematology·2026

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Immunotherapy·2026

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Frontiers in cellular and infection microbiology·2026

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Cureus·2026

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Frontiers in immunology·2026

Related Experiment Videos

Treatment of polycythemia vera with recombinant interferon

Related Concept Videos

A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Automated Information Extraction from Unstructured Hematopathology Reports to Support Response Assessment in Myeloproliferative Neoplasms.

DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).

A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.

Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.

Timing of autologous stem cell transplantation and induction response in central nervous system lymphoma.

Voriconazole versus itraconazole for antifungal prophylaxis in patients with graft-versus-host disease: A prospective randomized trial.

Diagnostic delay and clinical outcomes of paroxysmal nocturnal hemoglobinuria: a retrospective cohort study using Japanese claims data.

Dimensionality reduction enables MRD visualization in single-sample flow cytometric analysis in acute leukemia.

Metabolic mimic of inherited bone marrow failure: LMBRD1 (cblF) deficiency in an infant.

Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold.

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Related Experiment Videos

Treatment of polycythemia vera with recombinant interferon

Related Concept Videos

Related Articles